ClinConnect ClinConnect Logo
Search / Trial NCT06875999

Pet Therapy Effects on Pain, Emotional and Physiological Responses in Children Undergoing Allergy Testing

Launched by MEHTAP METİN KARAASLAN · Mar 12, 2025

Trial Information

Current as of May 09, 2025

Not yet recruiting

Keywords

Allergy Testing Children Animal Assisted Therapy Emotions

ClinConnect Summary

This clinical trial is studying how pet therapy, specifically using betta fish, can help reduce pain and emotional stress in young children undergoing allergy testing. Allergy tests, like the Skin Prick Test (SPT), are important for diagnosing allergies but can be stressful for kids, especially those aged 3 to 6. The research will involve 80 children who will be randomly divided into two groups: one experiencing pet therapy during the test and the other not. The goal is to see if being around fish can make the children feel better emotionally and physically during the procedure.

To be eligible for this study, children must be between 3 to 6 years old, have no previous allergy testing, and have stable health without chronic illnesses. Additionally, their mothers must be able to communicate and agree to participate. Families will be asked to join the study if they meet these criteria, and participants can expect to take part in a friendly environment where their emotional and physical responses will be carefully monitored. The findings from this trial could help develop better ways to ease children's anxiety during medical procedures.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • No previous allergy testing
  • 3-6 years old
  • Stable hemodynamics
  • No chronic disease
  • The child has no intellectual or neurological disability
  • The mother has no obstacle to communication
  • Mother is literate
  • Families and children agree to participate in the study.
  • Exclusion Criteria:
  • The child does not meet the inclusion criteria
  • The mother does not meet the inclusion criteria
  • Child's and mother's unwillingness to participate in the study

About Mehtap Meti̇n Karaaslan

Mehtap Metin Karaaslan is a dedicated clinical trial sponsor committed to advancing medical research and innovation. With a focus on enhancing patient outcomes, Ms. Karaaslan leads initiatives that prioritize rigorous study design, ethical standards, and regulatory compliance. Her expertise spans various therapeutic areas, and she fosters collaboration among multidisciplinary teams to ensure the successful execution of clinical trials. Through her leadership, she aims to contribute significantly to the development of novel therapies and improve the overall landscape of healthcare.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported